DaVita issued a statement applauding the Center for Medicare and Medicaid Innovation (CMMI)'s decision to extend the Kidney Care Choices (KCC) Model for an additional year. This extension provides continued stability for value-based care initiatives in kidney health.
Misha Palecek, chief transformation officer for DaVita, attributed the extension to the investments made by CMMI and participants, which are expected to result in long-term savings. The program's focus on comprehensive, collaborative care and patient engagement is driving encouraging health outcomes.
DaVita has been a dedicated participant in the government's value-based care initiative for twenty years, having doubled its Kidney Contracting Entity (KCE) footprint to 22 since 2022. The company remains committed to establishing a new standard for kidney care through integrated care systems alongside its nephrology partners.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.